• +1-646-491-9876
    • +91-20-67278686

    Search

    Male Hypogonadism Pipeline Review H2 2017

    Male Hypogonadism Pipeline Review H2 2017

    • Report Code ID: RW0001884130
    • Category Pharmaceuticals
    • No. of Pages 100
    • Publication Month Jul-17
    • Publisher Name Global Markets Direct
    Male Hypogonadism - Pipeline Review, H2 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Pipeline Review, H2 2017, provides an overview of the Male Hypogonadism (Male Health) pipeline landscape.

    Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis) . Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles and untreated sleep apnea. Treatment includes hormone replacement.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Male Hypogonadism - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Male Hypogonadism (Male Health) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 5, 1, 4, 4, 2, 1 and 4 respectively. Similarly, the Universities portfolio in Phase II stages comprises 1 molecules, respectively.

    Male Hypogonadism (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Male Hypogonadism (Male Health) .
    - The pipeline guide reviews pipeline therapeutics for Male Hypogonadism (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Male Hypogonadism (Male Health) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Male Hypogonadism (Male Health) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Male Hypogonadism (Male Health)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Male Hypogonadism (Male Health) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Male Hypogonadism (Male Health) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents 2
    List of Tables 4
    List of Figures 4
    Introduction 5
    Publisher Report Coverage 5
    Male Hypogonadism - Overview 6
    Male Hypogonadism - Therapeutics Development 7
    Pipeline Overview 7
    Pipeline by Companies 8
    Pipeline by Universities/Institutes 10
    Products under Development by Companies 11
    Products under Development by Universities/Institutes 13
    Male Hypogonadism - Therapeutics Assessment 14
    Assessment by Target 14
    Assessment by Mechanism of Action 16
    Assessment by Route of Administration 18
    Assessment by Molecule Type 20
    Male Hypogonadism - Companies Involved in Therapeutics Development 22
    Antares Pharma Inc 22
    Clarus Therapeutics Inc 22
    EndoCeutics Inc 23
    Ferring International Center SA 23
    Lipocine Inc 24
    M et P Pharma AG 24
    Medlab Clinical Ltd 25
    Merck & Co Inc 25
    Mereo Biopharma Group Plc 26
    Repros Therapeutics Inc 26
    TesoRx Pharma LLC 27
    The Female Health Company 27
    Viramal Ltd 28
    Male Hypogonadism - Drug Profiles 29
    BGS-649 - Drug Profile 29
    corifollitropin alfa - Drug Profile 31
    enclomiphene citrate - Drug Profile 33
    IAS-167A - Drug Profile 47
    Kisspeptin-10 - Drug Profile 48
    leuprolide acetate - Drug Profile 49
    Libidua - Drug Profile 50
    LPCN-1111 - Drug Profile 51
    MSS-722 - Drug Profile 53
    testosterone - Drug Profile 54
    testosterone - Drug Profile 60
    testosterone - Drug Profile 61
    testosterone - Drug Profile 63
    testosterone enanthate - Drug Profile 65
    testosterone propionate - Drug Profile 70
    testosterone undecanoate - Drug Profile 71
    testosterone undecanoate - Drug Profile 75
    testosterone undecanoate - Drug Profile 80
    testosterone undecanoate - Drug Profile 81
    testosterone undecanoate - Drug Profile 82
    testosterone undecanoate - Drug Profile 83
    testosterone undecanoate - Drug Profile 84
    Male Hypogonadism - Dormant Projects 85
    Male Hypogonadism - Discontinued Products 86
    Male Hypogonadism - Product Development Milestones 87
    Featured News & Press Releases 87
    Appendix 97
    Methodology 97
    Coverage 97
    Secondary Research 97
    Primary Research 97
    Expert Panel Validation 97
    Contact Us 97
    Disclaimer 98

    List of Tables

    Number of Products under Development for Male Hypogonadism, H2 2017
    Number of Products under Development by Companies, H2 2017
    Number of Products under Development by Universities/Institutes, H2 2017
    Products under Development by Companies, H2 2017
    Products under Development by Companies, H2 2017 (Contd..1) , H2 2017
    Products under Development by Universities/Institutes, H2 2017
    Number of Products by Stage and Target, H2 2017
    Number of Products by Stage and Mechanism of Action, H2 2017
    Number of Products by Stage and Route of Administration, H2 2017
    Number of Products by Stage and Molecule Type, H2 2017
    Male Hypogonadism - Pipeline by Antares Pharma Inc, H2 2017
    Male Hypogonadism - Pipeline by Clarus Therapeutics Inc, H2 2017
    Male Hypogonadism - Pipeline by EndoCeutics Inc, H2 2017
    Male Hypogonadism - Pipeline by Ferring International Center SA, H2 2017
    Male Hypogonadism - Pipeline by Lipocine Inc, H2 2017
    Male Hypogonadism - Pipeline by M et P Pharma AG, H2 2017
    Male Hypogonadism - Pipeline by Medlab Clinical Ltd, H2 2017
    Male Hypogonadism - Pipeline by Merck & Co Inc, H2 2017
    Male Hypogonadism - Pipeline by Mereo Biopharma Group Plc, H2 2017
    Male Hypogonadism - Pipeline by Repros Therapeutics Inc, H2 2017
    Male Hypogonadism - Pipeline by TesoRx Pharma LLC, H2 2017
    Male Hypogonadism - Pipeline by The Female Health Company, H2 2017
    Male Hypogonadism - Pipeline by Viramal Ltd, H2 2017
    Male Hypogonadism - Dormant Projects, H2 2017
    Male Hypogonadism - Discontinued Products, H2 2017

    List of Figures

    Number of Products under Development for Male Hypogonadism, H2 2017
    Number of Products under Development by Companies, H2 2017
    Number of Products by Targets, H2 2017
    Number of Products by Stage and Targets, H2 2017
    Number of Products by Mechanism of Actions, H2 2017
    Number of Products by Stage and Mechanism of Actions, H2 2017
    Number of Products by Routes of Administration, H2 2017
    Number of Products by Stage and Routes of Administration, H2 2017
    Number of Products by Molecule Types, H2 2017
    Number of Products by Stage and Molecule Types, H2 2017
    Antares Pharma Inc
    Clarus Therapeutics Inc
    EndoCeutics Inc
    Ferring International Center SA
    Lipocine Inc
    M et P Pharma AG
    Medlab Clinical Ltd
    Merck & Co Inc
    Mereo Biopharma Group Plc
    Repros Therapeutics Inc
    TesoRx Pharma LLC
    The Female Health Company
    Viramal Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//male-hypogonadism-pipeline-review-h2-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//male-hypogonadism-pipeline-review-h2-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//male-hypogonadism-pipeline-review-h2-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments